REG - Oxford Biomedica PLC - Holding(s) in Company <Origin Href="QuoteRef">OXB.L</Origin>

Oxford BioMedicaAnnouncement

02/09/2015 15:10

RNS Number : 8961X
Oxford Biomedica PLC
02 September 2015
For filings with the FSA include the annex

For filings with issuer exclude the annex


TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi


1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached:ii
Oxford Biomedica PLC
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights
X
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):


3. Full name of person(s) subject to the
notification obligation:iii
Third National Swedish Pension Fund
4. Full name of shareholder(s)
(if different from 3.):iv

5. Date of the transaction and date on
which the threshold is crossed or
reached:v
2015-09-01
6. Date on which issuer notified:
2015-09-02
7. Threshold(s) that is/are crossed or
reached: vi, vii
3%


8. Notified details:
A: Voting rights attached to sharesviii, ix
Class/type of
shares

if possible using
the ISIN CODE
Situation previous
to the triggering
transaction
Resulting situation after the triggering transaction
Number
of
Shares
Number
of
Voting
Rights
Number
of shares
Number of voting
rights
% of voting rights x
Direct
Direct xi
Indirect xii
Direct
Indirect
GB0006648157
78,317,715
78,317,715
77,176,027
77,176,027

2.99%



B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial
instrument
Expiration
date xiii
Exercise/
Conversion Period xiv
Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.
% of voting
rights






C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financial
instrument
Exercise price
Expiration date xvii
Exercise/
Conversion period xviii
Number of voting rights instrument refers to
% of voting rights xix, xx




Nominal
Delta



Total (A+B+C)
Number of voting rights
Percentage of voting rights
77,176,027
2.99%


9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable: xxi

Proxy Voting:
10. Name of the proxy holder:

11. Number of voting rights proxy holder will cease
to hold:

12. Date on which proxy holder will cease to hold
voting rights:



13. Additional information:


14. Contact name:

15. Contact telephone number:



Note: Annex should only be submitted to the FSA not the issuer
Annex: Notification of major interests in share

A: Identity of the persons or legal entity subject to the notification obligation
Full name 
(including legal form of legal entities)
Third National Swedish Pension Fund
Contact address 
(registered office for legal entities)
Vasagatan 7, 111 91 Stockholm, Sweden
Phone number & email
+468-555 17 100
Other useful information 
(at least legal representative for legal persons)
Mikael Sedolin


B: Identity of the notifier, if applicable
Full name
Sebastian Mossfeldt
Contact address
Vasagatan 7, 111 91 Stockholm, Sweden
Phone number & email
+468-555 17 162, Sebastian.mossfeldt@ap3.se
Other useful information
(e.g. functional relationship with the person or legal entity subject to the notification obligation)


C: Additional information

For notes on how to complete form TR-1 please see the FSA website.

This information is provided by RNS
The company news service from the London Stock Exchange
  END
HOLUUASRVRAKRAR